U.S. pharma large copyright scrapped two experimental weight loss pills final year—a when-daily pill, lotiglipron, resulting from elevated liver enzymes plus a two times-daily pill, danuglipron, due to robust Unintended effects—but CEO Albert Bourla has said the company is determined to “play and win” in the weight problems Place and in Jul